These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8503779

  • 1. Comparison of replication rates and pathogenicities between the SA14 parent and SA14-14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons.
    Hase T, Dubois DR, Summers PL, Downs MB, Ussery MA.
    Arch Virol; 1993; 130(1-2):131-43. PubMed ID: 8503779
    [Abstract] [Full Text] [Related]

  • 2. Virus-neuron interactions in the mouse brain infected with Japanese encephalitis virus.
    Hase T.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(3):161-70. PubMed ID: 8242175
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Liu X, Zhao D, Jia L, Xu H, Na R, Ge Y, Liu S, Yu Y, Li Y.
    Vaccine; 2018 Jul 25; 36(31):4650-4656. PubMed ID: 29954631
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Entry and replication of Japanese encephalitis virus in cultured neurogenic cells.
    Hase T, Summers PL, Ray P.
    J Virol Methods; 1990 Nov 25; 30(2):205-14. PubMed ID: 2262535
    [Abstract] [Full Text] [Related]

  • 7. Differences in haemagglutination activity and electrophoretic mobility of E protein between the parent SA14 and attenuated vaccine SA14-14-2 strains of Japanese encephalitis virus.
    Lee T, Komiya T, Watanabe K, Aizawa C, Hashimoto H.
    Acta Virol; 1995 Apr 25; 39(2):109-11. PubMed ID: 7676935
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ultrastructural changes of mouse brain neurons infected with Japanese encephalitis virus.
    Hase T, Summers PL, Dubois DR.
    Int J Exp Pathol; 1990 Aug 25; 71(4):493-505. PubMed ID: 2169298
    [Abstract] [Full Text] [Related]

  • 10. [Studies on the biological and genetic characteristics of a highly neurovirulent Japanese encephalitis virus strain SA4].
    Liu XY, Yu YX, Yue GZ, Yang LH, Jia LL, Dong GM.
    Bing Du Xue Bao; 2010 Jul 25; 26(4):265-70. PubMed ID: 20836378
    [Abstract] [Full Text] [Related]

  • 11. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F.
    Vaccine; 1999 Apr 09; 17(15-16):1869-82. PubMed ID: 10217584
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D, Li XF, Ye Q, Wang HJ, Deng YQ, Zhu SY, Zhang Y, Li SH, Qin CF.
    Vaccine; 2014 May 13; 32(23):2675-81. PubMed ID: 24709585
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.
    Gromowski GD, Firestone CY, Whitehead SS.
    J Virol; 2015 Jun 13; 89(12):6328-37. PubMed ID: 25855730
    [Abstract] [Full Text] [Related]

  • 16. Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes.
    Bhatt TR, Crabtree MB, Guirakhoo F, Monath TP, Miller BR.
    Am J Trop Med Hyg; 2000 Apr 13; 62(4):480-4. PubMed ID: 11220763
    [Abstract] [Full Text] [Related]

  • 17. Cytopathology of PC12 cells infected with Japanese encephalitis virus.
    Hase T, Summers PL, Ray P, Asafo-Adjei E.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992 Apr 13; 63(1):25-36. PubMed ID: 1362019
    [Abstract] [Full Text] [Related]

  • 18. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-2: a comparison with isolates of the virus covering a wide geographic area.
    Wills MR, Sil BK, Cao JX, Yu YX, Barrett AD.
    Vaccine; 1992 Apr 13; 10(12):861-72. PubMed ID: 1455912
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y.
    Vaccine; 2010 May 07; 28(21):3635-41. PubMed ID: 20226891
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
    Janewongwirot P, Puthanakit T, Anugulruengkitt S, Jantarabenjakul W, Phasomsap C, Chumket S, Yoksan S, Pancharoen C.
    Vaccine; 2016 Oct 17; 34(44):5279-5283. PubMed ID: 27628323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.